Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, April 2003, p. 1297-1300, Vol. 47, No. 4
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.4.1297-1300.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Imipenem Resistance in a Salmonella Clinical Strain Due to Plasmid-Mediated Class A Carbapenemase KPC-2
Vivi Miriagou,1 Leonidas S. Tzouvelekis,2 Shannon Rossiter,3 Eva Tzelepi,1 Frederick J. Angulo,3 and Jean M. Whichard3*
Laboratory of Bacteriology, Hellenic Pasteur Institute,1
Department of Microbiology, Medical School, University of Athens, Athens, Greece,2
Foodborne and Diarrheal Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia3
Received 29 July 2002/
Returned for modification 24 October 2002/
Accepted 2 January 2003

ABSTRACT
A
Salmonella enterica serotype Cubana isolate exhibiting resistance
to most ß-lactam antibiotics, including oxyimino-cephalosporins
and imipenem, was isolated from a 4-year-old boy with gastroenteritis
in Maryland. ß-Lactam resistance was mediated by a
conjugative plasmid that encoded KPC-2, a class A carbapenemase
previously found in a
Klebsiella pneumoniae isolate from the
Maryland area as well. Sequence analysis of the flanking regions
indicated a potential association of
blaKPC-2 with mobile structures.

INTRODUCTION
Resistance to expanded-spectrum oxyimino-cephalosporins among
Salmonella strains is mostly due to acquisition of plasmids
encoding various class A extended-spectrum ß-lactamases
(
1,
8,
13,
17,
19-
21). Production of plasmid-mediated class
C ß-lactamases by
Salmonella isolates has also been
described previously (
4,
22,
23). The emergence of such strains
may have serious implications because of the limitation of therapeutic
choices for patients with invasive
Salmonella infections and
by facilitation of the spread of
bla genes in the community.
We describe here an imipenem-resistant
Salmonella enterica serotype
Cubana isolate that produces the recently described KPC-2 ß-lactamase
(E. S. Moland, J. Johnson, J. A. Black, T. J. Lockhart, A. Hossain,
V. L. Herrera, N. D. Hanson, and K. S. Thomson, Abstr. 41st
Intersci. Conf. Antimicrob. Agents Chemother., abstr. 2226,
2001).

MATERIALS AND METHODS
Salmonella serotype Cubana was isolated in December 1998 from
a stool specimen of a 4-year-old boy with diarrhea in a hospital
in Maryland. The patient was chronically ill with Wiskott-Aldrich
syndrome. In the 6 months before isolation of serotype Cubana,
he had been hospitalized three times and had received intravenous
antibiotics. During each of those hospitalizations he had received
intravenous ß-lactams, including ceftriaxone and ceftazidime,
but not carbapenems. There was no history of recent travel.
The isolate (AM04707) was submitted to the Centers for Disease
Control and Prevention as part of the National Antimicrobial
Resistance Monitoring System for enteric bacteria (
http://www.cdc.gov/NARMS/)
and was subsequently forwarded to the Hellenic Pasteur Institute.
Escherichia coli K-12 strain 14R525 (Nalr) was used as the recipient in conjugation experiments. E. coli DH5
(GIBCO-BRL, Carlsbad, Calif.) was used for transformation. Chloramphenicol-resistant plasmid pBCSK(+) (Stratagene, La Jolla, Calif.) was used for cloning and expression of bla genes.
The MICs of ß-lactams were determined by an agar dilution technique (10). Susceptibilities to other antimicrobial agents were assessed by a disk diffusion method (11) and by a partial-range broth microdilution method (Sensititre; Trek Diagnostics; Westlake, Ohio), according to the instructions of the manufacturer.
Conjugation experiments were carried out in mixed broth cultures as described previously (5). Transconjugant clones were selected on Mueller-Hinton agar containing ampicillin (50 µg/ml) plus nalidixic acid (200 µg/ml). Plasmid DNA preparations were obtained by an alkaline lysis technique and resolved in 0.8% (wt/vol) agarose gels. Individual plasmids were excised as discrete bands from low-melting-point agarose (0.8%) and were subjected to partial digestion with various restriction enzymes including HindIII. Digests were ligated into the multicloning site of pBCSK(+). The resulting recombinant plasmids were used to transform E. coli DH5
competent cells. ß-Lactam-resistant transformants were selected on Luria-Bertani agar containing chloramphenicol (20 µg/ml) and ampicillin (50 µg/ml). The nucleotide sequences of the cloned fragments were determined with an ABI Prism 377 DNA sequencer (Perkin-Elmer, Applied Biosystems Division, Foster City, Calif.). Sequence similarity searches were performed with the BLAST program (available at the website of the National Center for Biotechnology Information).
ß-Lactamases were extracted in one of two ways. One method involved ultrasonic treatment of bacterial cells, followed by suspension in phosphate buffer (100 mM; pH 7.0) and clarification by centrifugation (Fig. 1A). A small-scale freeze-thaw method with modifications provided by J. W. Biddle and J. K. Rasheed was used for comparison of KPC-1 and KPC-2 (3) (Fig. 1B). Detection of carbapenemase activity was performed by bioassay as described previously (24). Analytical isoelectric focusing was performed in polyacrylamide gels containing ampholytes (pH range, 3.5 to 9.5; APBiotech, Piscataway, N.J.). ß-Lactamase activity was visualized with nitrocefin (Oxoid Ltd., Basingstoke, United Kingdom, or Becton-Dickinson, Lexington, Ky.). In situ inhibition of ß-lactamase activity was performed by soaking the gels in solutions containing clavulanate (0.5 mM), tazobactam (0.5 mM), or EDTA (5 mM). Maximum hydrolysis rates for various ß-lactam substrates were estimated by UV spectrophotometry, and inhibition by clavulanate and tazobactam was assessed by using nitrocefin as the reporter substrate. The respective procedures were as described previously (5).
Nucleotide sequence accession number.
The sequence of the 5.2-kb fragment of pST-H1 containing
blaKPC-2 has been submitted to the GenBank database and assigned accession
number
AF481906.

RESULTS
Salmonella serotype Cubana 4707 exhibited either resistance
or decreased susceptibility to all ß-lactams tested
including ß-lactam-ß-lactamase inhibitor
combinations, oxyimino-cephalosporins, aztreonam, and carbapenems.
In the presence of clavulanic acid, the MICs of ceftazidime
and imipenem were decreased by 4 and 2 doubling dilutions, respectively
(Table
1). The isolate was also resistant to streptomycin, trimethoprim,
and sulfamethoxazole. The isolate was susceptible to nalidixic
acid (MIC,

4 µg/ml) and ciprofloxacin (MIC,

0.015 µg/ml).
View this table:
[in this window]
[in a new window]
|
TABLE 1. Susceptibilities to antibiotics of Salmonella serotype Cubana 4707, an E. coli transconjugant containing wild-type plasmid pST4707, and an E. coli DH5 transconjugant containing plasmid pSTH-1
|
Transfer of ß-lactam resistance to
E. coli by conjugation
was successful. Transconjugants exhibited a phenotype of resistance
to ß-lactams similar to that of
Salmonella serotype
Cubana 4707 (Table
1). They were also resistant to streptomycin,
trimethoprim, and sulfonamides. Analysis of plasmid DNA indicated
transfer of a plasmid (pST4707) that, according to conventional
gel electrophoresis in a 0.8% gel, was between 24.5 and 42 MDa
(data not shown).
ß-Lactamase extracts from Salmonella serotype Cubana 4707 and E. coli(pST4707) were positive in a carbapenemase bioassay performed as described by Yigit et al. (24; data not shown). Isoelectric focusing demonstrated that the extracts contained two ß-lactamases with apparent pIs of 5.4 and 6.7, respectively (Fig. 1). Both enzymes were inhibited in situ by clavulanic acid and tazobactam but not by EDTA. The ß-lactamase with a pI of 5.4 is consistent with a TEM-1 enzyme, the presence of which was supported by sequencing of 95% of the blaTEM-1-coding region (data not shown).
Cloning of a 5.2-kb HindIII fragment of pST4707 yielded a pBCSK(+) derivative (pST-H1) which mediated resistance only to ß-lactams. E. coli(pST-H1) exhibited resistance or decreased susceptibility to all ß-lactam antibiotics tested, including carbapenems (Table 1). Also, it was positive in the carbapenemase bioassay and produced a single ß-lactamase with a pI of 6.7 (Fig. 1). Hydrolysis experiments performed with extracts from E. coli(pST-H1) showed that the rate of imipenem hydrolysis relative to that of penicillin G, which was set at 100, was 45 ± 5. The value for cefotaxime was 58 ± 3. Hydrolysis rates for ceftazidime and cefoxitin were too low to obtain reliable values, although the slightly elevated cefoxitin MIC indicates some degree of hydrolysis (Table 1). The hydrolysis rates for nitrocefin and cephalothin were significantly higher than that for penicillin G (2.4- and 3.1-fold, respectively). The 50% inhibitory concentrations of clavulanate and tazobactam were 1.4 and 0.08 µM, respectively.
The 5.2-kb HindIII fragment included an 882-bp open reading frame (ORF) that differed by only 1 bp (nucleotide 520) from blaKPC-1 found in Klebsiella pneumoniae (24). An identical sequence (blaKPC-2), also from K. pneumoniae, has recently appeared in GenBank (accession number AY034847; Moland et al., 41st ICAAC). The deduced protein, KPC-2, differs from KPC-1 by one amino acid residue (KPC-2 contains Gly instead of Ser at position 175). Gly-175 is also found in SME-1, NMC-A, and IMI-1 (9, 12, 16). KPC-2 contained the motifs typical for class A ß-lactamases (7) as well as residues characteristic for the carbapenem-hydrolyzing enzymes of this molecular class, including Cys at positions 69 and 238, His at position 105, and a hydroxylated residue (Thr) at position 237 (14, 15, 18). The putative secretory signal sequence comprises 24 residues. The mature KPC-2 has a predicted molecular weight of 28,480. The calculated pI (6.4) differs slightly from the apparent pI of the native ß-lactamase. The pI reported for KPC-1 was 6.7 (24). When isoelectric focusing was done with both ß-lactamases, the pI of K. pneumoniae KPC-1 was very similar to that of KPC-2 from Salmonella serotype Cubana (Fig. 1).
The flanking sequences of blaKPC-2 (120 bp upstream, including the ribosome binding site and the -10 and -35 regions, and 300 bp downstream) were identical to those reported for blaKPC-1 (24). Analysis of the rest of the sequence of the 5.2-kb fragment showed at least four additional ORFs (orf1 to orf4) (Fig. 2). The respective putative peptides (P1 through P4) were significantly similar to proteins associated with transposable elements (Table 2). P1 was highly similar to the C terminus of a transposase A (TnpA) found in the Tn3 family of transposons from Pseudomonas putida (6). P2 and P3 displayed similarity to a TnpA and a transposition helper protein, respectively, found in Ralstonia solanacearum. P4 shared a moderate degree of similarity with putative transposases described in Burkholderia cepacia and Ralstonia spp.

DISCUSSION
KPC-2, along with KPC-1 (
24), SME-1 (
9), NMC-A (
12), and IMI-1
(
16), comprise a small group of class A ß-lactamases
(functional group 2f [
2,
15]) with potent carbapenemase activities.
The KPC enzymes seem to differ from the rest of the group in
that they hydrolyze oxyimino-cephalosporins more efficiently.
KPC-2 conferred levels of resistance to ß-lactams
that were comparable to those conferred by KPC-1 (
24). The two
enzymes, however, were expressed in different systems, and they
also differed by an amino acid residue of the putative omega
loop. The latter structure is significant in determining the
catalytic properties of class A ß-lactamases (
7).
Hence, differences in the substrate specificity cannot be ruled
out.
The high degree of homology between blaKPC-1 and blaKPC-2 and the identity of their flanking sequences indicate that these variant bla genes could be parts of a single structure. However, KPC-2-encoding plasmid pST4707 was self-transferable, while the blaKPC-1-encoding plasmid could not be conjugated into E. coli (24). Also, the blaKPC-1-encoding plasmid, unlike pST4707, neither encoded TEM nor mediated resistance to antibiotics other than ß-lactams. Therefore, it can be speculated that the blaKPC variants resulted from insertion of a similar or common mobile element into different plasmid backgrounds. Sequencing data are compatible with this notion, although the existence of a transposable element was not proven.
KPC-1 was found in a K. pneumoniae isolate from a hospital in North Carolina. KPC-producing K. pneumoniae strains have also been found in a Maryland hospital (Moland et al., 41st ICAAC). The isolation of Salmonella serotype Cubana 4707, also in Maryland, indicates a certain degree of spread of blaKPC genes in the United States. The plasmid locations of these genes and their association with possibly mobile structures may facilitate their spread. Continued surveillance is essential to monitor for the potential spread of blaKPC genes among Salmonella strains.

ACKNOWLEDGMENTS
We thank Jennifer Nelson, David Blythe, Dipti Shah, and David
I. Wheeler for contributions to this work.

FOOTNOTES
* Corresponding author. Mailing address: National Center for Infectious Diseases, MS G29, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30333. Phone: (404) 639-2000. Fax: (404) 639-4290. E-mail:
zyr3{at}cdc.gov.


REFERENCES
1 - Bradford, P. A., Y. Yang, D. Sahm, I. Grop, D. Gardovska, and G. Storch. 1998. CTX-M5, a novel cefotaxime hydrolyzing ß-lactamase from an outbreak of Salmonella typhimurium in Latvia. Antimicrob. Agents Chemother. 42:1980-1984.[Abstract/Free Full Text]
2 - Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for ß-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.[Medline]
3 - Bush, K., and S. B. Singer. 1989. Effective cooling allows sonication to be used for liberation of ß-lactamases from gram-negative bacteria. J. Antimicrob. Chemother. 24:82-84.[Free Full Text]
4 - Fey, P., P. Safranek, M. E. Rupp, E. F. Dunne, E. Ribot, P. C. Iwen, P. A. Bradford, F. J. Angulo, and S. H. Hinrichs. 2000. Ceftriaxone-resistant Salmonella infection acquired by a child from cattle. N. Engl. J. Med. 342:1242-1249.[Abstract/Free Full Text]
5 - Giakkoupi, P., L. S. Tzouvelekis, A. Tsakris, V. Loukova, D. Sofianou, and E. Tzelepi. 2000. IBC-1, a novel integron-associated class A ß-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain. Antimicrob. Agents Chemother. 44:2247-2253.[Abstract/Free Full Text]
6 - Lauf, U., C. Muller, and H. Herrmann. 1998. The transposable elements resident on the plasmids of Pseudomonas putida strain H, Tn5501 and Tn5502, are cryptic transposons of the Tn3 family. Mol. Gen. Genet. 259:674-678.[CrossRef][Medline]
7 - Matagne, A., J. Lamotte-Brasseur, and J.-M. Frere. 1998. Catalytic properties of class A ß-lactamases: efficiency and diversity. Biochem. J. 330:581-598.
8 - Morosini, M. I., R. Canton, J. Martinez-Beltran, M. C. Negri, J. C. Perez-Diaz, F. Baquero, and J. Blazquez. 1995. New extended-spectrum TEM-type ß-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak. Antimicrob. Agents Chemother. 39:458-461.[Abstract/Free Full Text]
9 - Naas, T., L. Wandel, W. Sougakoff, D. M. Livermore, and P. Nordmann. 1994. Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A ß-lactamase, Sme-1, from Serratia marcescens S6. Antimicrob. Agents Chemother. 38:1262-1270.[Abstract/Free Full Text]
10 - National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A4 (M100-S7). National Committee for Clinical Laboratory Standards, Wayne, Pa.
11 - National Committee for Clinical Laboratory Standards. 1997. Performance standards for antimicrobial disk susceptibility tests, 6th ed. Approved standard M2-A6 (M100-S7). National Committee for Clinical Laboratory Standards, Wayne, Pa.
12 - Nordmann, P., S. Mariotte, T. Naas, R. Labia, and M.-H. Nicolas. 1993. Biochemical properties of a carbapenem-hydrolyzing ß-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrob. Agents Chemother. 37:939-946.[Abstract/Free Full Text]
13 - Poupart, M. C., C. Chanal, D. Sirot, R. Labia, and J. Sirot. 1991. Identification of CTX-2, a novel cefotaximase from a Salmonella mbandaka isolate. Antimicrob. Agents Chemother. 35:1498-1500.[Abstract/Free Full Text]
14 - Raquet, X., J. Lamotte-Brasseur, F. Bouillenne, and J.-M. Frere. 1997. A disulfide bridge near the active site of carbapenem-hydrolyzing class A ß-lactamases might explain their unusual substrate profile. Proteins 27:47-58.[CrossRef][Medline]
15 - Rasmussen, B. A., and K. Bush. 1997. Carbapenem-hydrolyzing ß-lactamases. Antimicrob. Agents Chemother. 41:223-232.[Medline]
16 - Rasmussen, B. A., K. Bush, D. Keeney, Y. Yang, R. Hare, C. O'Gara, and A. A. Medeiros. 1996. Characterization of IMI-1 ß-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrob. Agents Chemother. 40:2080-2086.[Abstract]
17 - Revathi, G., K. P. Shannon, P. D. Stapleton, B. K. Jain, and G. L. French. 1998. An outbreak of extended-spectrum beta-lactamase-producing Salmonella senftenberg in a burns ward. J. Hosp. Infect. 40:295-302.[CrossRef][Medline]
18 - Sougakoff, W., T. Naas, P. Nordmann, E. Collatz, and V. Jarlier. 1999. Role of Ser-237 in the substrate specificity of the carbapenem-hydrolyzing class A ß-lactamase Sme-1. Biochim. Biophys. Acta 1433:153-158.[CrossRef][Medline]
19 - Tassios, P. T., M. Gazouli, E. Tzelepi, H. Milch, N. Kozlova, S. V. Sidorenko, N. J. Legakis, and L. S. Tzouvelekis. 1999. Spread of a Salmonella typhimurium clone resistant to expanded-spectrum cephalosporins in three European countries. J. Clin. Microbiol. 37:3774-3777.[Abstract/Free Full Text]
20 - Vahaboglu, H., L. M. Hall, L. Mulazimoglu, S. Dodanli, I. Yildirim, and D. M. Livermore. 1995. Resistance to extended-spectrum cephalosporins, caused by PER-1 beta-lactamase, in Salmonella typhimurium from Istanbul, Turkey. J. Med. Microbiol. 43:294-299.[Abstract/Free Full Text]
21 - Villa, L., C. Pezzella, F. Tosini, P. Visca, A. Petrucca, and A. Carattoli. 2000. Multiple-antibiotic resistance mediated by structurally related IncL/M plasmids carrying an extended-spectrum ß-lactamase gene and a class 1 integron. Antimicrob. Agents Chemother. 44:2911-2914.[Abstract/Free Full Text]
22 - Winokur, P. L., A. Brueggemann, D. L. DeSalvo, L. Hoffman, M. D. Apley, E. K. Uhlenhopp, M. A. Pfaller, and G. V. Doern. 2000. Animal and human multidrug-resistant, cephalosporin-resistant Salmonella isolates expressing a plasmid-mediated CMY-2 AmpC ß-lactamase. Antimicrob. Agents Chemother. 44:2777-2783.[Abstract/Free Full Text]
23 - Winokur, P. L., D. L. Vonstein, L. J. Hoffman, E. K. Uhlenhopp, and G. V. Doern. 2001. Evidence for transfer of CMY-2 AmpC ß-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrob. Agents Chemother. 45:2716-2722.[Abstract/Free Full Text]
24 - Yigit, H., A. M. Queenan, G. J. Anderson, A. Domenech-Sanchez, J. W. Biddle, C. D. Steward, S. Alberti, K. Bush, and F. C. Tenover. 2001. Novel carbapenem-hydrolyzing ß-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:1151-1161.[Abstract/Free Full Text]
Antimicrobial Agents and Chemotherapy, April 2003, p. 1297-1300, Vol. 47, No. 4
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.4.1297-1300.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Shen, P., Wei, Z., Jiang, Y., Du, X., Ji, S., Yu, Y., Li, L.
(2009). Novel Genetic Environment of the Carbapenem-Hydrolyzing {beta}-Lactamase KPC-2 among Enterobacteriaceae in China. Antimicrob. Agents Chemother.
53: 4333-4338
[Abstract]
[Full Text]
-
Kitchel, B., Rasheed, J. K., Patel, J. B., Srinivasan, A., Navon-Venezia, S., Carmeli, Y., Brolund, A., Giske, C. G.
(2009). Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258. Antimicrob. Agents Chemother.
53: 3365-3370
[Abstract]
[Full Text]
-
Gootz, T. D., Lescoe, M. K., Dib-Hajj, F., Dougherty, B. A., He, W., Della-Latta, P., Huard, R. C.
(2009). Genetic Organization of Transposase Regions Surrounding blaKPC Carbapenemase Genes on Plasmids from Klebsiella Strains Isolated in a New York City Hospital. Antimicrob. Agents Chemother.
53: 1998-2004
[Abstract]
[Full Text]
-
Wolter, D. J., Kurpiel, P. M., Woodford, N., Palepou, M.-F. I., Goering, R. V., Hanson, N. D.
(2009). Phenotypic and Enzymatic Comparative Analysis of the Novel KPC Variant KPC-5 and Its Evolutionary Variants, KPC-2 and KPC-4. Antimicrob. Agents Chemother.
53: 557-562
[Abstract]
[Full Text]
-
Cole, J. M., Schuetz, A. N., Hill, C. E., Nolte, F. S.
(2009). Development and Evaluation of a Real-Time PCR Assay for Detection of Klebsiella pneumoniae Carbapenemase Genes. J. Clin. Microbiol.
47: 322-326
[Abstract]
[Full Text]
-
Petrella, S., Ziental-Gelus, N., Mayer, C., Renard, M., Jarlier, V., Sougakoff, W.
(2008). Genetic and Structural Insights into the Dissemination Potential of the Extremely Broad-Spectrum Class A {beta}-Lactamase KPC-2 Identified in an Escherichia coli Strain and an Enterobacter cloacae Strain Isolated from the Same Patient in France. Antimicrob. Agents Chemother.
52: 3725-3736
[Abstract]
[Full Text]
-
Hindiyeh, M., Smollen, G., Grossman, Z., Ram, D., Davidson, Y., Mileguir, F., Vax, M., Ben David, D., Tal, I., Rahav, G., Shamiss, A., Mendelson, E., Keller, N.
(2008). Rapid Detection of blaKPC Carbapenemase Genes by Real-Time PCR. J. Clin. Microbiol.
46: 2879-2883
[Abstract]
[Full Text]
-
Tibbetts, R., Frye, J. G., Marschall, J., Warren, D., Dunne, W.
(2008). Detection of KPC-2 in a Clinical Isolate of Proteus mirabilis and First Reported Description of Carbapenemase Resistance Caused by a KPC {beta}-Lactamase in P. mirabilis. J. Clin. Microbiol.
46: 3080-3083
[Abstract]
[Full Text]
-
Rotimi, V. O., Jamal, W., Pal, T., Sovenned, A., Albert, M. J.
(2008). Emergence of CTX-M-15 type extended-spectrum {beta}-lactamase-producing Salmonella spp. in Kuwait and the United Arab Emirates. J Med Microbiol
57: 881-886
[Abstract]
[Full Text]
-
Cai, J. C., Zhou, H. W., Zhang, R., Chen, G.-X.
(2008). Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates Possessing the Plasmid-Mediated Carbapenem-Hydrolyzing {beta}-Lactamase KPC-2 in Intensive Care Units of a Chinese Hospital. Antimicrob. Agents Chemother.
52: 2014-2018
[Abstract]
[Full Text]
-
Rasheed, J. K., Biddle, J. W., Anderson, K. F., Washer, L., Chenoweth, C., Perrin, J., Newton, D. W., Patel, J. B.
(2008). Detection of the Klebsiella pneumoniae Carbapenemase Type 2 Carbapenem-Hydrolyzing Enzyme in Clinical Isolates of Citrobacter freundii and K. oxytoca Carrying a Common Plasmid. J. Clin. Microbiol.
46: 2066-2069
[Abstract]
[Full Text]
-
Naas, T., Cuzon, G., Villegas, M.-V., Lartigue, M.-F., Quinn, J. P., Nordmann, P.
(2008). Genetic Structures at the Origin of Acquisition of the {beta}-Lactamase blaKPC Gene. Antimicrob. Agents Chemother.
52: 1257-1263
[Abstract]
[Full Text]
-
Zhang, R., Yang, L., Cai, J. C., Zhou, H. W., Chen, G.-X.
(2008). High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression. J Med Microbiol
57: 332-337
[Abstract]
[Full Text]
-
Walther-Rasmussen, J., Hoiby, N.
(2007). Class A carbapenemases. J Antimicrob Chemother
60: 470-482
[Abstract]
[Full Text]
-
Anderson, K. F., Lonsway, D. R., Rasheed, J. K., Biddle, J., Jensen, B., McDougal, L. K., Carey, R. B., Thompson, A., Stocker, S., Limbago, B., Patel, J. B.
(2007). Evaluation of Methods To Identify the Klebsiella pneumoniae Carbapenemase in Enterobacteriaceae. J. Clin. Microbiol.
45: 2723-2725
[Abstract]
[Full Text]
-
Queenan, A. M., Bush, K.
(2007). Carbapenemases: the Versatile {beta}-Lactamases. Clin. Microbiol. Rev.
20: 440-458
[Abstract]
[Full Text]
-
Villegas, M. V., Lolans, K., Correa, A., Kattan, J. N., Lopez, J. A., Quinn, J. P., and the Colombian Nosocomial Resistance Study Grou,
(2007). First Identification of Pseudomonas aeruginosa Isolates Producing a KPC-Type Carbapenem-Hydrolyzing {beta}-Lactamase. Antimicrob. Agents Chemother.
51: 1553-1555
[Abstract]
[Full Text]
-
Wei, Z.-Q., Du, X.-X., Yu, Y.-S., Shen, P., Chen, Y.-G., Li, L.-J.
(2007). Plasmid-Mediated KPC-2 in a Klebsiella pneumoniae Isolate from China. Antimicrob. Agents Chemother.
51: 763-765
[Abstract]
[Full Text]
-
Navon-Venezia, S., Chmelnitsky, I., Leavitt, A., Schwaber, M. J., Schwartz, D., Carmeli, Y.
(2006). Plasmid-Mediated Imipenem-Hydrolyzing Enzyme KPC-2 among Multiple Carbapenem-Resistant Escherichia coli Clones in Israel.. Antimicrob. Agents Chemother.
50: 3098-3101
[Abstract]
[Full Text]
-
Virginia Villegas, M., Lolans, K., Correa, A., Jose Suarez, C., Lopez, J. A., Vallejo, M., Quinn, J. P., the Colombian Nosocomial Resistance Study Group,
(2006). First Detection of the Plasmid-Mediated Class A Carbapenemase KPC-2 in Clinical Isolates of Klebsiella pneumoniae from South America.. Antimicrob. Agents Chemother.
50: 2880-2882
[Abstract]
[Full Text]
-
Landman, D., Salvani, J. K., Bratu, S., Quale, J.
(2005). Evaluation of Techniques for Detection of Carbapenem-Resistant Klebsiella pneumoniae in Stool Surveillance Cultures. J. Clin. Microbiol.
43: 5639-5641
[Abstract]
[Full Text]
-
Rankin, S. C., Whichard, J. M., Joyce, K., Stephens, L., O'Shea, K., Aceto, H., Munro, D. S., Benson, C. E.
(2005). Detection of a blaSHV Extended-Spectrum {beta}-Lactamase in Salmonella enterica Serovar Newport MDR-AmpC. J. Clin. Microbiol.
43: 5792-5793
[Abstract]
[Full Text]
-
Paterson, D. L., Bonomo, R. A.
(2005). Extended-Spectrum {beta}-Lactamases: a Clinical Update. Clin. Microbiol. Rev.
18: 657-686
[Abstract]
[Full Text]
-
Naas, T., Nordmann, P., Vedel, G., Poyart, C.
(2005). Plasmid-Mediated Carbapenem-Hydrolyzing {beta}-Lactamase KPC in a Klebsiella pneumoniae Isolate from France. Antimicrob. Agents Chemother.
49: 4423-4424
[Full Text]
-
Bratu, S., Mooty, M., Nichani, S., Landman, D., Gullans, C., Pettinato, B., Karumudi, U., Tolaney, P., Quale, J.
(2005). Emergence of KPC-Possessing Klebsiella pneumoniae in Brooklyn, New York: Epidemiology and Recommendations for Detection. Antimicrob. Agents Chemother.
49: 3018-3020
[Abstract]
[Full Text]
-
Bratu, S., Landman, D., Haag, R., Recco, R., Eramo, A., Alam, M., Quale, J.
(2005). Rapid Spread of Carbapenem-Resistant Klebsiella pneumoniae in New York City: A New Threat to Our Antibiotic Armamentarium. Arch Intern Med
165: 1430-1435
[Abstract]
[Full Text]
-
Bratu, S., Landman, D., Alam, M., Tolentino, E., Quale, J.
(2005). Detection of KPC Carbapenem-Hydrolyzing Enzymes in Enterobacter spp. from Brooklyn, New York. Antimicrob. Agents Chemother.
49: 776-778
[Abstract]
[Full Text]
-
Giakkoupi, P., Tzouvelekis, L. S., Daikos, G. L., Miriagou, V., Petrikkos, G., Legakis, N. J., Vatopoulos, A. C.
(2005). Discrepancies and Interpretation Problems in Susceptibility Testing of VIM-1-Producing Klebsiella pneumoniae Isolates. J. Clin. Microbiol.
43: 494-496
[Abstract]
[Full Text]
-
Woodford, N., Tierno, P. M. Jr., Young, K., Tysall, L., Palepou, M.-F. I., Ward, E., Painter, R. E., Suber, D. F., Shungu, D., Silver, L. L., Inglima, K., Kornblum, J., Livermore, D. M.
(2004). Outbreak of Klebsiella pneumoniae Producing a New Carbapenem- Hydrolyzing Class A {beta}-Lactamase, KPC-3, in a New York Medical Center. Antimicrob. Agents Chemother.
48: 4793-4799
[Abstract]
[Full Text]
-
Hossain, A., Ferraro, M. J., Pino, R. M., Dew, R. B. III, Moland, E. S., Lockhart, T. J., Thomson, K. S., Goering, R. V., Hanson, N. D.
(2004). Plasmid-Mediated Carbapenem-Hydrolyzing Enzyme KPC-2 in an Enterobacter sp.. Antimicrob. Agents Chemother.
48: 4438-4440
[Abstract]
[Full Text]
-
Yigit, H., Queenan, A. M., Rasheed, J. K., Biddle, J. W., Domenech-Sanchez, A., Alberti, S., Bush, K., Tenover, F. C.
(2003). Carbapenem-Resistant Strain of Klebsiella oxytoca Harboring Carbapenem-Hydrolyzing {beta}-Lactamase KPC-2. Antimicrob. Agents Chemother.
47: 3881-3889
[Abstract]
[Full Text]